US Broker Ratings

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing a 239.96% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX), a promising player in the biotechnology sector, has caught the eye of investors with a remarkable potential upside of 239.96%. This clinical-stage vaccine innovation company is..

Nuvalent, Inc. (NUVL): Biotechnology Innovator with a 44% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is garnering significant attention within the biotechnology sector. With a robust market capitalization of $5.6 billion, Nuvalent is..

BeOne Medicines Ltd. (ONC): Investor Outlook on a Biotech Powerhouse with 29.81% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling potential upside of 29.81% as per analyst ratings. Based in..

Molina Healthcare Inc (MOH) Stock Analysis: Potential 20.98% Upside Amid Strong Growth and Analyst Confidence

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is garnering significant attention from investors due to its robust performance metrics and attractive growth potential. With..

Avidity Biosciences, Inc. (RNA) Investor Outlook: An 84% Potential Upside with Innovative Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing investor attention in the biotechnology sector with a promising potential upside of 84.29%, driven by its innovative approach in RNA therapeutics. As a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 9.56% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands out in the bustling healthcare sector as a key player in the medical devices industry. With a solid market capitalization of $13.24..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unpacking the 76% Potential Upside

Revolution Medicines, Inc. (RVMD), a trailblazer in the biotechnology industry, focuses on the development of innovative therapies targeting RAS-addicted cancers. With a market capitalization of $7.65 billion, this clinical-stage precision..

Exact Sciences Corporation (EXAS) Investor Outlook: Exploring a 25.51% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within diagnostics and research, continues to attract investor interest. With a market capitalization of $10.35 billion, the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking the 43% Potential Upside for Investors

For investors with a keen eye on the healthcare sector, Bio-Rad Laboratories, Inc. (NYSE: BIO) represents an intriguing opportunity. With a market capitalization of $6.05 billion, this U.S.-based company operates..

Medpace Holdings (MEDP) Stock Analysis: Navigating a 65.83% ROE in the Healthcare Sector

Investors eyeing the healthcare sector often consider companies that exhibit strong financial performance and a robust market presence. Medpace Holdings, Inc. (NASDAQ: MEDP), a clinical contract research organization, stands out..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 13.92% Potential Upside in the Medical Devices Sector

Merit Medical Systems, Inc. (NASDAQ: MMSI) is gaining attention in the healthcare sector, particularly among investors seeking opportunities in medical instruments and supplies. With a market cap of $5.63 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 17.63% Potential Upside Amid Strong Buy Ratings

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, offers a compelling investment opportunity with an impressive potential upside of 17.63%. Amid a robust buy consensus..

CVS Health Corporation (CVS) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and compelling upside potential. With a market capitalization of..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 22.76% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Los Angeles, California, RadNet operates an..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 19.49% Potential Upside for Investors

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is garnering attention from individual investors due to its robust potential upside of 19.49%. As a leader in..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 29% Upside Potential in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB) stands as a prominent player in the healthcare sector, particularly within the realm of drug manufacturing. With a market capitalization of $19.51 billion, this Massachusetts-based biotech..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking a 59% Potential Upside with Promising CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is drawing attention in the biotechnology sector with its innovative approach to treating central nervous system (CNS) disorders. As the company stands at the forefront..

Cytokinetics, Incorporated (CYTK) Stock Report: Unpacking a Potential 124.61% Upside in the Biotech Arena

In the dynamic world of biotechnology, Cytokinetics, Incorporated (NASDAQ: CYTK) emerges as an intriguing player, particularly for investors with an appetite for high-growth potential. With its focus on groundbreaking muscle..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.54% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, is making waves in the stock market with a potential upside of 19.54%. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a Potential 58% Upside in Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is not just about diagnostics and therapeutics; it’s about promising growth potential. With a market capitalization of $5.64..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds